DANIEL MUSHER to Age Factors
This is a "connection" page, showing publications DANIEL MUSHER has written about Age Factors.
Connection Strength
0.238
-
The impact of statin and macrolide use on early survival in patients with pneumococcal pneumonia. Am J Med Sci. 2013 Mar; 345(3):173-7.
Score: 0.067
-
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults. Hum Vaccin. 2011 Sep; 7(9):919-28.
Score: 0.060
-
Acute Cardiac Events in Patients With Severe Limb Infection. Int J Low Extrem Wounds. 2018 Dec; 17(4):261-267.
Score: 0.025
-
Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia. Mayo Clin Proc. 2014 Jan; 89(1):60-8.
Score: 0.018
-
Pneumococcal vaccination for patients with spinal cord injury. Arch Phys Med Rehabil. 1993 Dec; 74(12):1354-7.
Score: 0.018
-
Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis. 1993 Jul; 17(1):66-73.
Score: 0.017
-
Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012 Feb 14; 125(6):773-81.
Score: 0.015
-
Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection? J Infect Dis. 1990 Apr; 161(4):736-40.
Score: 0.014
-
Pneumococcal vaccine after 15 years of use. Another view. Arch Intern Med. 1994 Nov 28; 154(22):2531-5.
Score: 0.005